S&P 500   2,612.13 (-99.20%)
DOW   22,150.97 (+5.22%)
QQQ   191.98 (+4.70%)
AAPL   253.10 (+4.84%)
FB   159.97 (+3.76%)
MSFT   160.26 (+4.18%)
GOOGL   1,145.28 (+4.54%)
AMZN   1,945.80 (+2.06%)
CGC   14.18 (+7.02%)
NVDA   262.25 (+7.52%)
BABA   194.68 (+4.04%)
MU   45.31 (+9.92%)
GE   7.24 (+6.47%)
TSLA   515.06 (+7.30%)
AMD   45.71 (+7.33%)
T   28.83 (+4.99%)
ACB   0.85 (+4.94%)
F   4.65 (+9.42%)
NFLX   373.34 (+3.20%)
BAC   21.29 (+6.29%)
GILD   76.83 (-1.76%)
DIS   97.56 (+3.92%)
PRI   88.23 (+9.34%)
S&P 500   2,612.13 (-99.20%)
DOW   22,150.97 (+5.22%)
QQQ   191.98 (+4.70%)
AAPL   253.10 (+4.84%)
FB   159.97 (+3.76%)
MSFT   160.26 (+4.18%)
GOOGL   1,145.28 (+4.54%)
AMZN   1,945.80 (+2.06%)
CGC   14.18 (+7.02%)
NVDA   262.25 (+7.52%)
BABA   194.68 (+4.04%)
MU   45.31 (+9.92%)
GE   7.24 (+6.47%)
TSLA   515.06 (+7.30%)
AMD   45.71 (+7.33%)
T   28.83 (+4.99%)
ACB   0.85 (+4.94%)
F   4.65 (+9.42%)
NFLX   373.34 (+3.20%)
BAC   21.29 (+6.29%)
GILD   76.83 (-1.76%)
DIS   97.56 (+3.92%)
PRI   88.23 (+9.34%)
S&P 500   2,612.13 (-99.20%)
DOW   22,150.97 (+5.22%)
QQQ   191.98 (+4.70%)
AAPL   253.10 (+4.84%)
FB   159.97 (+3.76%)
MSFT   160.26 (+4.18%)
GOOGL   1,145.28 (+4.54%)
AMZN   1,945.80 (+2.06%)
CGC   14.18 (+7.02%)
NVDA   262.25 (+7.52%)
BABA   194.68 (+4.04%)
MU   45.31 (+9.92%)
GE   7.24 (+6.47%)
TSLA   515.06 (+7.30%)
AMD   45.71 (+7.33%)
T   28.83 (+4.99%)
ACB   0.85 (+4.94%)
F   4.65 (+9.42%)
NFLX   373.34 (+3.20%)
BAC   21.29 (+6.29%)
GILD   76.83 (-1.76%)
DIS   97.56 (+3.92%)
PRI   88.23 (+9.34%)
S&P 500   2,612.13 (-99.20%)
DOW   22,150.97 (+5.22%)
QQQ   191.98 (+4.70%)
AAPL   253.10 (+4.84%)
FB   159.97 (+3.76%)
MSFT   160.26 (+4.18%)
GOOGL   1,145.28 (+4.54%)
AMZN   1,945.80 (+2.06%)
CGC   14.18 (+7.02%)
NVDA   262.25 (+7.52%)
BABA   194.68 (+4.04%)
MU   45.31 (+9.92%)
GE   7.24 (+6.47%)
TSLA   515.06 (+7.30%)
AMD   45.71 (+7.33%)
T   28.83 (+4.99%)
ACB   0.85 (+4.94%)
F   4.65 (+9.42%)
NFLX   373.34 (+3.20%)
BAC   21.29 (+6.29%)
GILD   76.83 (-1.76%)
DIS   97.56 (+3.92%)
PRI   88.23 (+9.34%)
Log in

NASDAQ:HQYHealthequity Stock Price, Forecast & News

$43.58
+2.49 (+6.06 %)
(As of 04/6/2020 10:25 AM ET)
Add
Compare
Today's Range
$42.75
Now: $43.58
$44.18
50-Day Range
$40.54
MA: $61.77
$87.73
52-Week Range
$34.40
Now: $43.58
$88.78
Volume21,917 shs
Average Volume1.42 million shs
Market Capitalization$3.09 billion
P/E Ratio67.05
Dividend YieldN/A
Beta1.57
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.
Read More
Healthequity logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.03 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
CUSIPN/A
Phone801-727-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$531.99 million
Cash Flow$2.25 per share
Book Value$14.54 per share

Profitability

Net Income$39.66 million

Miscellaneous

Employees2,931
Market Cap$3.09 billion
Next Earnings Date6/2/2020 (Estimated)
OptionableOptionable

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.


Healthequity (NASDAQ:HQY) Frequently Asked Questions

How has Healthequity's stock been impacted by COVID-19 (Coronavirus)?

Healthequity's stock was trading at $50.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HQY stock has decreased by 13.4% and is now trading at $43.58. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Healthequity?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Healthequity.

When is Healthequity's next earnings date?

Healthequity is scheduled to release its next quarterly earnings announcement on Tuesday, June 2nd 2020. View our earnings forecast for Healthequity.

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) posted its earnings results on Monday, March, 16th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.23 by $0.16. The firm earned $201.20 million during the quarter, compared to analysts' expectations of $199.95 million. Healthequity had a net margin of 7.46% and a return on equity of 10.54%. The company's quarterly revenue was up 165.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.21 EPS. View Healthequity's earnings history.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity issued an update on its FY21 earnings guidance on Monday, March, 16th. The company provided EPS guidance of $1.70-$1.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.80. The company issued revenue guidance of $770-$790 million, compared to the consensus revenue estimate of $824.18 million.

What price target have analysts set for HQY?

13 Wall Street analysts have issued 12 month price targets for Healthequity's stock. Their forecasts range from $47.00 to $90.00. On average, they expect Healthequity's share price to reach $70.83 in the next year. This suggests a possible upside of 62.5% from the stock's current price. View analysts' price targets for Healthequity.

Has Healthequity been receiving favorable news coverage?

Media coverage about HQY stock has trended very negative on Monday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Healthequity earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutHealthequity.

Are investors shorting Healthequity?

Healthequity saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 4,841,900 shares, an increase of 26.1% from the February 27th total of 3,840,000 shares. Based on an average daily trading volume, of 1,197,000 shares, the short-interest ratio is currently 4.0 days. Currently, 7.0% of the company's shares are short sold. View Healthequity's Current Options Chain.

Who are some of Healthequity's key competitors?

What other stocks do shareholders of Healthequity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Input Capital (INP), Circle Oil (COP), Shopify (SHOP), Alibaba Group (BABA), Paypal (PYPL), Twilio (TWLO), Square (SQ), Netflix (NFLX) and Okta (OKTA).

Who are Healthequity's key executives?

Healthequity's management team includes the following people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 51)
  • Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 54)

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $43.58.

How big of a company is Healthequity?

Healthequity has a market capitalization of $3.09 billion and generates $531.99 million in revenue each year. The company earns $39.66 million in net income (profit) each year or $1.38 on an earnings per share basis. Healthequity employs 2,931 workers across the globe. View additional information about Healthequity.

What is Healthequity's official website?

The official website for Healthequity is http://www.healthequity.com/.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Coverage Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel